Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
RWLK

RWLK - ReWalk Robotics Ltd Stock Price, Fair Value and News

$5.100.00 (0.00%)
Market Closed

Price Targets

RWLK Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RWLK Price Action

RWLK RSI Chart

RWLK Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RWLK Valuation

Market Cap

92.4M

Price/Earnings (Trailing)

-3.1

Price/Sales (Trailing)

3.77

EV/EBITDA

-3.07

Price/Free Cashflow

-5.35

RWLK Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

RWLK Fundamentals

RWLK Revenue

Revenue (TTM)

24.5M

Rev. Growth (Yr)

1.09%

Rev. Growth (Qtr)

8.23%

RWLK Earnings

Earnings (TTM)

-29.8M

Earnings Growth (Yr)

-2.79%

Earnings Growth (Qtr)

51.69%

RWLK Profitability

Operating Margin

37.49%

EBT Margin

-121.74%

Return on Equity

-233.98%

Return on Assets

-128.82%

Free Cashflow Yield

-18.7%

RWLK Investor Care

Shares Dilution (1Y)

101.32%

Diluted EPS (TTM)

-2.99

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202525.4M24.4M24.5M0
202417.9M23.3M25.0M25.7M
20235.9M5.6M9.1M13.9M
20225.5M5.7M4.6M5.5M
20214.9M4.7M5.9M6.0M
20204.1M4.8M4.4M4.4M
20196.5M5.7M5.3M4.9M
20186.8M6.6M6.5M6.5M
20176.3M7.5M7.8M7.8M
20165.2M5.4M5.6M5.9M
20153.9M3.8M3.8M3.7M
20142.2M2.8M3.4M4.0M
20130001.6M
2012000972.0K
Get all data in R, Python etc through our Historical Stock Data APIs

About ReWalk Robotics Ltd

RWLK
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
 CEO
 WEBSITErewalk.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES56

ReWalk Robotics Ltd Frequently Asked Questions

RWLK is the stock ticker symbol of ReWalk Robotics Ltd. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Oct 31 2025, market cap of ReWalk Robotics Ltd is 92.38 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check RWLK's fair value in chart for subscribers.

The fair value guage provides a quick view whether RWLK is over valued or under valued. Whether ReWalk Robotics Ltd is cheap or expensive depends on the assumptions which impact ReWalk Robotics Ltd's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for RWLK.

As of Fri Oct 31 2025, RWLK's PE ratio (Price to Earnings) is -3.1 and Price to Sales (PS) ratio is 3.77. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. RWLK PE ratio will change depending on the future growth rate expectations of investors.